Affini-T
8 employees on LinkedIn · 4 known investors
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.
Investors · 4
Frequently asked questions
- What does Affini-T do?
- Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.
- Who are Affini-T's investors?
- Affini-T's investors include Agent Capital, Olive Tree Capital, Service Provider Capital, Humboldt.